Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/22/2008CA2668766A1 Sigma ligands for neuronal regeneration and functional recovery
05/22/2008CA2668744A1 Compounds and methods for treating protein folding disorders
05/22/2008CA2668742A1 Renin inhibitors
05/22/2008CA2668724A1 Darusentan oral dosage form
05/22/2008CA2668662A1 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/22/2008CA2668634A1 Organic compounds
05/22/2008CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008CA2668026A1 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy
05/22/2008CA2667587A1 Methods for treatment of cochlear and vestibular disorders
05/22/2008CA2667569A1 Thionucleosides and pharmaceutical applications
05/22/2008CA2666903A1 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
05/22/2008CA2666837A1 Arylsulfonamide compounds
05/22/2008CA2665698A1 Use of spiro-oxindole compounds as therapeutic agents
05/22/2008CA2664866A1 Methods and collagen products for tissue repair
05/22/2008CA2661338A1 Macrocyclic inhibitors of hepatitis c virus
05/22/2008CA2659407A1 Nanoparticle compositions
05/22/2008CA2611727A1 Adhesive preparation
05/22/2008CA2611655A1 Skin-piercing device for treatment of acne
05/21/2008EP1923465A1 Inhibitor protein for the WNT signal pathway
05/21/2008EP1923393A1 Crystalline form of tiotropium bromide and urea
05/21/2008EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them.
05/21/2008EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
05/21/2008EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder
05/21/2008EP1923387A1 Acylguanidine derivative or salt thereof
05/21/2008EP1923386A2 Carbamate caspase inhibitors and uses thereof
05/21/2008EP1923382A1 [18F] labelled L-glutamic acid, [18F] labelled glutamine, their derivatives, their use and processes for their preparation
05/21/2008EP1923074A1 Orally disintegratable tablet
05/21/2008EP1923073A2 Combination medication comprising a PDE-5 inhibitor
05/21/2008EP1923072A1 Prophylactic/therapeutic agent for cancer
05/21/2008EP1923068A1 System and methods for opening obstructed biological conduits
05/21/2008EP1923066A1 Composition comprising rooibos tea and conjugated linoleic acid (CLA)
05/21/2008EP1923064A2 Use of amine polymer for lowering serum glucose
05/21/2008EP1923063A2 Compositions and methods for combination antiviral therapy
05/21/2008EP1923062A1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
05/21/2008EP1923061A1 Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
05/21/2008EP1923060A1 Combinations of a sphingolipid and an HMG-CoA reductase inhibitor for treating hypercholesterolemia
05/21/2008EP1923058A1 Coated pharmaceutical composition comprising an S1P agonist or modulator
05/21/2008EP1923057A1 Atorvastatin pharmaceutical formulation
05/21/2008EP1923056A1 Pharmaceutical single dosage form
05/21/2008EP1923055A1 Freeze-dried pharmaceutical composition comprising an S1P agonist or modulator
05/21/2008EP1923054A1 Fast disintegrating pharmaceutical composition comprising an S1P agonist or modulator
05/21/2008EP1923053A1 Pharmaceutical compositions comprising nilotinib or its salt
05/21/2008EP1923052A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
05/21/2008EP1923049A1 Pharmaceutical compositions comprising a bisphosphonate compound
05/21/2008EP1922420A2 METHOD AND SUBSTANCES FOR ISOLATING miRNAs
05/21/2008EP1922321A1 Pyrazoloý1,5-a¨pyrimidine compounds and pharmaceutical compositions containing them
05/21/2008EP1922320A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
05/21/2008EP1922318A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases
05/21/2008EP1922317A2 Amide and carbamate derivatives of n-{2-ý4-amino-2- (ethoxymethyl)-1h-imidazoý4,5-c¨quinolin-1-yl¨-1,1-dimethylethyl}methanesulfonamide and methods
05/21/2008EP1922316A1 Benzimidazole thiophene compounds as plk modulators
05/21/2008EP1922314A1 Delta and epsilon crystal forms of imatinib mesylate
05/21/2008EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists
05/21/2008EP1922312A1 Thiazole compounds and their use as pgd2 antagonists
05/21/2008EP1922310A2 Triazole derivatives useful as axl inhibitors
05/21/2008EP1922309A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
05/21/2008EP1922307A2 Heterocyclic inhibitors of mek and methods of use thereof
05/21/2008EP1922305A1 New salt ii
05/21/2008EP1922304A2 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe
05/21/2008EP1922303A2 Purification of paricalcitol
05/21/2008EP1922135A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process
05/21/2008EP1922094A1 Methods and devices for lymphatic targeting
05/21/2008EP1922086A1 Targeted protein kinase c inhibitors and uses thereof
05/21/2008EP1922085A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
05/21/2008EP1922077A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
05/21/2008EP1922076A2 Use of lipid conjugates in cystic fibrosis and applications thereof
05/21/2008EP1922075A2 Adjuvant chemotherapy for anaplastic gliomas
05/21/2008EP1922074A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma.
05/21/2008EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers
05/21/2008EP1922072A2 Melanocortin receptor-specific piperazine compounds with diamine groups
05/21/2008EP1922071A2 Diazaspirodecane orexin receptor antagonists
05/21/2008EP1922070A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma
05/21/2008EP1922069A2 Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use
05/21/2008EP1922068A2 Inhibitors of voltage-gated sodium channels
05/21/2008EP1922067A1 Modified green tea polyphenol formulations
05/21/2008EP1922066A2 Topiramate compositions for treatment of headache
05/21/2008EP1922065A2 Novel formulations comprising fenofibrate and a statin, and related methods of treatment
05/21/2008EP1922063A1 Method of treating pain in patients
05/21/2008EP1922062A2 Method of treatment or prevention of age-related macular degeneration
05/21/2008EP1922061A2 Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin
05/21/2008EP1922059A2 Stabilized and preserved ketotifen ophthalmic compositions
05/21/2008EP1921919A2 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
05/21/2008EP1921917A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/21/2008EP1921916A2 Genistein inhibition of transthyretin amyloidosis
05/21/2008EP1921915A2 Prevention of neurodegeneration by macrolide antibiotics
05/21/2008EP1831191B1 Chroman derivatives and their use as 5-ht receptor ligands
05/21/2008EP1827417A4 Enhanced occlusive effect photodynamic therapy
05/21/2008EP1809292B1 Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
05/21/2008EP1768948B1 Substituted amino compounds as 5-ht/na uptake inhibitors
05/21/2008EP1765755A4 Regulators of bacterial signalling pathways
05/21/2008EP1756095B1 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
05/21/2008EP1737838B1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
05/21/2008EP1689410B1 Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
05/21/2008EP1681296B1 Epimeredi glycoside a, the formulation containing thereof and their preparation method
05/21/2008EP1670487A4 Therapeutic formulations
05/21/2008EP1635820B1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight
05/21/2008EP1603893B1 Ep4 receptor antagonists
05/21/2008EP1603573B1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention
05/21/2008EP1603558B1 Process for preparation of perindopril and salts thereof
05/21/2008EP1603557A4 Synthesis of peloruside a and analogs thereof for use as antitumor agents
1 ... 3255 3256 3257 3258 3259 3260 3261 3262 3263 3264 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 ... 7860